Wednesday, July 19, 2023 | The Latest Research, Commentary, And News From Health Affairs
Dear John,
Julia Dennett and Gregg Gonsalves today released an ahead-of-print article examining how OxyContin's marketing practices in 1996 have led to serious long-term health problems even today.
Their
study compares outcomes between states with high and low levels of exposure to early OxyContin marketing both before and after the 2010 reformulation of OxyContin.
Dennett and Gonsalves conclude that "exposure to initial OxyContin marketing statistically significantly increased fatal synthetic opioid-related overdose rates; incidence of acute hepatitis A, hepatitis B, and hepatitis C; and infective endocarditis-related mortality rates after the 2010 OxyContin reformulation."
These findings
suggest that OxyContin marketing in 1996 is related to adverse long-term health outcomes over twenty-five years later.
Supported by CVS Health and featuring health equity experts as they examine private-sector initiatives and responsibility to advance health equity, the series includes articles exploring private-sector efforts to challenge injustices in health care.
In the latest article in the series, Wizdom Powell from Headspace Health asks whether the private sector can lead the mental health equity crisis.
This series will publish new articles through Friday, July 21.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking
content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
